Biotronik Can't Seek $100M From J&J Over Stents: Judge

Law360, New York (October 24, 2011, 7:34 PM EDT) -- German drugmaker Biotronik AG can't seek $100 million in lost profits in a suit claiming a Johnson & Johnson unit breached a supply contract by issuing a bogus CoStar stent recall, a New York judge ruled in an order filed Friday.

Judge Bernard J. Fried rejected J&J unit Conor Medsystems Inc.'s summary judgment bid, but hobbled Biotronik's case by ruling that it couldn't go after Conor for lost profits — the only damages it was seeking.

Conor pulled its CoStar stents off the market in 2007...
To view the full article, register now.